Collegium Reports Third Quarter Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. AMZN
10. LEN

Go back to Collegium Reports Third Quarter Financial Results and Provides Corporate Update

Collegium (COLL) Xtampza ER Sales More than Double Expectations - William Blair

November 9, 2017 9:50 AM EST

William Blair analyst Tim Lugo reiterated an Outperform rating on Collegium Pharmaceutical (NASDAQ: COLL) following Q3 results which showed Xtampza ER sales for the third quarter came in at $11.95 million, well above our expectation of $4.8 million and consensus of $5.3 million. Lugo notes that... More